Top 10: Life Sciences Companies

Life sciences companies are playing an increasingly important role in addressing global health challenges through scientific innovation, advanced research and cutting-edge technologies.

As demand grows for more effective treatments, personalised medicine and improved healthcare outcomes, leading organisations are investing heavily in areas such as biotechnology, pharmaceuticals, diagnostics, artificial intelligence and digital health.

At the same time, the sector faces the challenge of expanding access to healthcare, accelerating scientific discovery and meeting evolving regulatory and patient expectations.

Healthcare Digital ranks the Top 10 Life Sciences Companies by revenue, highlighting the organisations driving breakthroughs in medicine, research and healthcare innovation worldwide.

10. Novo Nordisk

Revenue: US$49bn

CEO: Maziar Mike Doustdar

Founded: 1989

 A major global life sciences company dedicated to improving health outcomes through innovative research, development and delivery of treatments for serious chronic diseases is Novo Nordisk.

With a strong focus on diabetes, obesity, cardiovascular disease and rare disorders, the company combines scientific excellence with patient-centred care.

Guided by transparency, collaboration and ethical practices, Novo Nordisk advances breakthrough therapies, including GLP-1 medicines, while ensuring clinical trial integrity and patient privacy.

Its long-term commitment to innovation continues to expand access to life-changing healthcare worldwide.

9. Sanofi

Revenue: US$51.6bn

CEO: Belén Garijo

Founded: 1973

Sanofi is a research-driven, AI-powered biopharmaceutical company dedicated to advancing healthcare through innovative medicines and vaccines.

Leveraging deep expertise in immunology, oncology, neurology, rare diseases and vaccines, the company develops transformative therapies that improve patient outcomes worldwide.

By combining breakthrough science, advanced technology platforms and artificial intelligence, Sanofi accelerates drug discovery and development while maintaining a strong focus on patient needs.

Its commitment to sustainability, inclusion and collaboration supports its mission to improve lives and protect public health for future generations.

8. Novartis

Revenue: US$54.5bn

CEO: Vas Narasimhan

Founded: 1996

When reimagining healthcare through scientific discovery and advanced research Novartis, an innovative medicines company, is leading the way.

Focusing on areas of high unmet need, including cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology and gene therapy, the company develops transformative treatments that improve and extend lives.

Its research is powered by cutting-edge platforms such as gene and cell therapy, radioligand therapy, xRNA and artificial intelligence.

Through collaboration, clinical innovation and patient-centred care, Novartis works to deliver breakthrough medicines worldwide.

7.  Merck & Co / MSD

Revenue: US$58.1bn

CEO: Robert Davis

Founded: 1891

Merck & Co, MSD in the UK, is a global research-intensive biopharmaceutical company committed to using leading-edge science to save and improve lives.

With more than 130 years of innovation, the company develops medicines, vaccines, biologic therapies and animal health solutions that address some of the world’s most pressing health challenges.

Its research focuses on oncology, vaccines, infectious diseases, immunology, neuroscience, cardiometabolic, respiratory and ophthalmic conditions.

Through scientific excellence, strategic partnerships and patient-centred innovation, MSD advances breakthrough therapies that improve health outcomes worldwide.

6. AstraZeneca

Revenue: US$58.7bn

CEO: Pascal Soriot

Founded: 1999

AstraZeneca is a vast biopharmaceutical company dedicated to transforming healthcare through innovative science and patient-centred solutions.

With expertise in oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, rare diseases and vaccines, the company develops life-changing medicines that address major health challenges.

AstraZeneca combines cutting-edge research, strong partnerships and a commitment to sustainability to improve patient outcomes and health system resilience.

Guided by its purpose of pushing the boundaries of science, the company works to create healthier people, communities and environments worldwide.

5. AbbVie

Revenue: US$61.2bn

CEO: Robert Michael

Founded: 2013

A global, research-driven biopharmaceutical company committed to discovering and delivering innovative medicines is AbbVie, addressing complex health challenges and improving lives.

With expertise in immunology, oncology, neuroscience, eye care and aesthetics, the company combines advanced science, precision medicine, AI and patient-focused research to develop transformative healthcare solutions.

Guided by integrity, innovation and inclusion, AbbVie works closely with healthcare professionals, researchers and patient communities to expand access to care, elevate treatment standards and create lasting impact for patients worldwide.

4. Pfizer

Revenue: US$62.6bn

CEO: Albert Bourla

Founded: 1849

The prominent biopharmaceutical company, Pfizer, is dedicated to discovering, developing and delivering innovative medicines and vaccines that improve patient outcomes worldwide.

With expertise in oncology, vaccines, rare diseases, inflammation and immunology, internal medicine and anti-infectives, the company combines cutting-edge science, clinical research and strategic collaborations to address significant healthcare challenges.

Pfizer invests heavily in research and development, leveraging advanced technologies, artificial intelligence and global partnerships to accelerate innovation.

Through its patient-focused approach, Pfizer works to advance healthcare, expand access to treatments and improve lives globally.

3. Eli Lilly

Revenue: US$65.2bn

CEO: David Ricks

Founded: 1876

Eli Lilly is a research-driven pharmaceutical company focused on improving health through innovative medicines, patient support services and scientific discovery.

The company combines cutting-edge research, clinical development and digital health solutions to address major health challenges including Alzheimer’s disease, cancer, diabetes, obesity, cardiovascular disease, immunology and pain management.

Eli Lilly emphasises patient-centred care by supporting access to treatment, clinical trials, educational resources and healthcare professionals.

With a strong commitment to innovation, transparency and inclusivity in research, Lilly leverages technologies such as AI, genetics, precision medicine and advanced therapeutics to accelerate breakthroughs and deliver life-changing medicines to patients worldwide.

2. Roche

Revenue: US$79.5bn

CEO: Dr Thomas Schinecker

Founded: 1896

A key healthcare company that combines pharmaceuticals, diagnostics and digital health solutions is Roche, addressing some of the world’s most challenging diseases.

Founded in 1896 and headquartered in Basel, Roche serves patients in more than 100 countries and is one of the world’s largest biotechnology companies and the global leader in in-vitro diagnostics.

Guided by patient needs, Roche focuses on preventing, diagnosing, treating and curing diseases that place significant burdens on individuals, families and healthcare systems.

The company’s research and innovation efforts span key therapeutic areas including oncology, neurology, ophthalmology, immunology, infectious diseases, respiratory conditions, women’s health, haematology, inflammatory bowel diseases and cardiometabolic disorders.

Roche integrates advanced diagnostics with targeted medicines to enable more personalised healthcare.

Through extensive clinical research, global partnerships and a strong commitment to sustainability, access to healthcare and inclusion, Roche aims to improve health outcomes and help people live healthier, longer lives worldwide.

1. Johnson & Johnson

Revenue: US$94.2bn

CEO: Joaquin Duato

Founded: 1886

Johnson & Johnson is a global healthcare company dedicated to tackling some of the world’s most complex health challenges through innovative medicines, medical technologies and scientific research.

Founded in 1886, the company combines expertise in pharmaceuticals and medical devices to improve patient outcomes and advance healthcare worldwide.

Its Innovative Medicine division focuses on developing transformative treatments in oncology, immunology, neuroscience and cardiopulmonary diseases, using rigorous science and patient-centred innovation to address areas of significant unmet need.

Through its MedTech division, Johnson & Johnson develops advanced medical technologies across cardiovascular care, orthopaedics, surgery and vision, delivering smarter, less invasive and more personalised healthcare solutions.

With approximately 140,000 employees worldwide and operations spanning research, development, manufacturing and commercialisation, the company aims to prevent disease, improve treatment outcomes and enhance quality of life.

Johnson & Johnson prioritises patients, healthcare professionals, communities and innovation to create lasting impact across global healthcare systems.